CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to advance computational techniques for drug design in life sciences by developing efficient parallelization methods and establishing a competence network. This will enable researchers to utilize advanced computing resources for analyzing biological data and improving drug discovery processes.
Life Science is developing into one of the largest e- Infrastructure users in Europe, in part due to the ever-growing amount of biological data.
Modern drug design typically includes both sequence bioinformatics, in silico virtual screening, and free energy calculations, e.g. of drug binding.
This development will accelerate tremendously, and puts high demands on simulation software and support services. e-Infrastructure projects such as PRACE/DEISA have made important advances on hardware and s…
KUNGLIGA TEKNISKA HOEGSKOLAN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Sweden, Alingsas
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
